Regulation of protein translation through mRNA structure influences MHC class I loading and T cell recognition

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 27, 2008, Pages 9319-9324

  Tellam, Judy ^a   Smith, Corey ^a   Rist, Michael ^a   Webb, Natasha ^a   Cooper, Leanne ^a   Vuocolo, Tony ^b   Connolly, Geoff ^a   Tscharke, David C ^c   Devoy, Michael P ^c   Khanna, Rajiv ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b CSIRO   (Australia)

^c AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

Antigen processing; EBV encoded nuclear antigen 1; Immune evasion; Protein synthesis

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN;

AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOREGULATION; IN VITRO STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RNA ANALYSIS; RNA STRUCTURE; RNA TRANSLATION;

ANTIGEN PRESENTATION; BASE SEQUENCE; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CODON; EPITOPES; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; GENE EXPRESSION REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEIC ACID CONFORMATION; OLIGONUCLEOTIDES, ANTISENSE; PROTEIN BIOSYNTHESIS; PROTEIN STRUCTURE, TERTIARY; PURINES; RNA STABILITY; RNA, MESSENGER;

HUMAN HERPESVIRUS 4;

EID: 48249117542     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0801968105     Document Type: Article

References (28)

1. Mocarski ES, Jr (2002) Immunomodulation by cytomegaloviruses: Manipulative strategies beyond evasion. Trends Microbiol 10:332-339.
2. Khanna R, et al. (1993) EBV peptide epitope sensitization restores human cytotoxic T cell recognition of Burkitt's lymphoma cells. Evidence for a critical role for ICAM-2. J Immunol 150:5154-5162.
3. Gandhi MK, Khanna R (2004) Human cytomegalovirus: Clinical aspects, immune regulation, and emerging treatments. Lancet Infect Dis 4:725-738.
4. Khanna R, Moss DJ, Gandhi M (2005) Applications of emerging immunotherapeutic strategies for Epstein-Barr virus-associated malignancies. Nat Clin Pract Oncol 2:138-149.
5. Bauer D, Tampe R (2002) Herpes viral proteins blocking the transporter associated with antigen processing TAP: From genes to function and structure. Curr Top Microbiol Immunol 269:87-99.
6. Park B, et al. (2004) Human cytomegalovirus inhibits tapasin-dependent peptide loading and optimization of the MHC class I peptide cargo for immune evasion. Immunity 20:71-85.
7. Kimura Y, et al. (2005) Escape mutations alter proteasome processing of major histocompatibility complex class I-restricted epitopes in persistent hepatitis C virus infection. J Virol 79:4870-4876.
8. + T cells in vivo: The key to rational vaccine design. Annu Rev Immunol 23:651-682.
9. Yewdell JW, Reits E, Neefjes J (2003) Making sense of mass destruction: Quantitating MHC class I antigen presentation. Nat Rev Immunol 3:952-961.
10. Yewdell JW, Schubert U, Bennink JR (2001) At the crossroads of cell biology and immunology: DRiPs and other sources of peptide ligands for MHC class I molecules. J Cell Sci 114:845-851.
11. Yin Y, Manoury B, Fahraeus R (2003) Self-inhibition of synthesis and antigen presentation by Epstein-Barr virus-encoded EBNA1. Science 301:1371-1374.
12. Levitskaya J, et al. (1997) Inhibition of ubiquitin/proteasome- dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1. Proc Natl Acad Sci USA 94:12616-12621.
13. + T cell epitopes. J Exp Med 204:525-532.
14. Cristillo AD, et al. (2001) Double-stranded RNA as a not-self alarm signal: To evade, most viruses purine-load their RNAs, but some (HTLV-1, Epstein-Barr) pyrimidine-load. J Theor Biol 208:475-491.
15. Jacobson AB, Zuker M (1993) Structural analysis by energy dot plot of a large mRNA. J Mol Biol 233:261-269.
16. Zuker M (2003) Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res 31:3406-3415.
17. Nakamura Y, Gojobori T, Ikemura T (1999) Codon usage tabulated from the international DNA sequence databases: Its status 1999. Nucleic Acids Res 27:292.
18. Gonzalez-Garay ML, Cabral F (1995) Overexpression of an epitope-tagged β-tubulin in Chinese hamster ovary cells causes an increase in endogenous α-tubulin synthesis. Cell Motil Cytoskeleton 31:259-272.
19. Porgador A, et al. (1997) Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody. Immunity 6:715-726.
20. Liu WJ, et al. (2002) Codon modified human papillomavirus type 16 E7 DNA vaccine enhances cytotoxic T lymphocyte induction and antitumor activity. Virology 301:43-52.
21. Jones RJ, et al. (2003) Epstein-Barr virus nuclear antigen 1 (EBNA1)-induced cytotoxicity in epithelial cells is associated with EBNA1 degradation and processing. Virology 313:663-676.
22. Ramage AD, et al. (1997) Improved EBV-based shuttle vector system: Dicistronic mRNA couples the synthesis of the Epstein-Barr nuclear antigen-1 protein to neomycin resistance. Gene 197:83-89.
23. Burrows SR, et al. (1992) The specificity of recognition of a cytotoxic T lymphocyte epitope. Eur J Immunol 22:191-195.
24. Carbone FR, Bevan MJ (1989) Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunization. J Exp Med 169:603-612.
25. + T cell epitopes from Epstein-Barr virus-encoded nuclear antigen 1. J Exp Med 199:1421-1431.
26. +T cell determinants to enable rational design and characterization of smallpox vaccines. J Exp Med 201:95-104.
27. Princiotta MF, et al. (2003) Quantitating protein synthesis, degradation, and endogenous antigen processing. Immunity 18:343-354.
28. Overton WR (1988) Modified histogram subtraction technique for analysis of flow cytometry data. Cytometry 9:619-626.